Akero Therapeutics Inc Working Capital to Net Assets Ratio
Akero Therapeutics Inc working capital to net assets ratio. Akero Therapeutics Inc (AKRO) has a Working Capital to Net Assets ratio of 73.8% as of September 2025. Working capital of $706.88 Million (current assets of $754.53 Million minus current liabilities of $47.65 Million) is measured against net assets of $957.64 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Akero Therapeutics Inc (2017–2024)
Working capital to net assets ratio of Akero Therapeutics Inc from 2017 to 2024. This chart shows how Akero Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 73.8%, reflecting working capital of $706.88 Million against net assets of $957.64 Million USD. Explore AKRO long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Akero Therapeutics Inc Working Capital to Net Assets Ratio by Year (2017–2024)
Akero Therapeutics Inc working capital to net assets ratio by year from 2017 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Akero Therapeutics Inc from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see AKRO asset base.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 97.4% | $730.63 Million | $750.11 Million | $770.38 Million | $39.75 Million | ▼ -3.6 pp |
| 2023 | 101.0% | $540.83 Million | $535.31 Million | $559.96 Million | $19.13 Million | ▼ -1.9 pp |
| 2022 | 102.9% | $336.09 Million | $326.56 Million | $355.17 Million | $19.08 Million | ▲ +3.3 pp |
| 2021 | 99.6% | $168.45 Million | $169.11 Million | $193.58 Million | $25.13 Million | ▼ -0.2 pp |
| 2020 | 99.8% | $258.23 Million | $258.71 Million | $271.35 Million | $13.11 Million | ▼ -0.1 pp |
| 2019 | 100.0% | $128.68 Million | $128.73 Million | $138.05 Million | $9.37 Million | ▲ +249.8 pp |
| 2018 | -149.8% | $74.79 Million | $-49.92 Million | $77.13 Million | $2.34 Million | ▼ -140.7 pp |
| 2017 | -9.1% | $416.00K | $-4.56 Million | $638.00K | $222.00K | — |